Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-19-003729
Filing Date
2019-04-01
Accepted
2019-04-01 06:34:09
Documents
1
Period of Report
2019-04-01

Document Format Files

Seq Description Document Type Size
1 SELUMETINIB GETS BREAKTHROUGH THERAPY DESIGNATION a5844u.htm 6-K 47188
  Complete submission text file 0001654954-19-003729.txt   48313
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 19718724
SIC: 2834 Pharmaceutical Preparations